Company Overview of Sunil Healthcare Ltd.
Sunil Healthcare Limited manufactures and sells hard gelatin capsule shells primarily in India. Its hard gelatin capsules shells is a pharmaceutical intermediary used by pharmaceutical and food supplement companies as a container for administering various medicines and food supplements. The company offers its products under the SUNLOC brand name. In addition, it is involved in trading food products. The company also exports its products. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.
Panchsheel Commercial Complex
New Delhi, 110049
Founded in 1973
Key Executives for Sunil Healthcare Ltd.
Chairman and Managing Director
Total Annual Compensation: $1.6M
Compensation as of Fiscal Year 2014.
Sunil Healthcare Ltd. Key Developments
Sunil Healthcare Ltd., Board Meeting, Mar 25, 2015
Mar 26 15
Sunil Healthcare Ltd., Board Meeting, Mar 25, 2015. Agenda: To review the performance of non-independent directors and the board as a whole; to review the performance of the chairperson of the company, taking into account the views of executive directors and non-executive directors; and to assess the quality, quantity and timeliness of flow of information between the company managements and the board that is necessary for the board to effectively and reasonably perform their duties.
Sunil Healthcare Ltd. Announces Standalone Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014
Feb 11 15
Sunil Healthcare Ltd. announced standalone unaudited earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations of INR 199.433 million against INR 149.286 million a year ago. Profits from operations before other income, finance cost and exceptional items was INR 22.281 million against INR 24.072 million a year ago. profit from ordinary activities before tax was INR 14.333 million against INR 20.260 million a year ago. Net profit for the period was INR 9.362 million or INR 0.91 per basic and diluted share against INR 12.902 million or INR 1.26 per basic and diluted share a year ago.
For the half year, the company reported net sales/income from operations of INR 551.690 million against INR 445.724 million a year ago. Profits from operations before other income, finance cost and exceptional items was INR 57.482 million against INR 51.740 million a year ago. profit from ordinary activities before tax was INR 40.2 million against INR 35.306 million a year ago. Net profit for the period was INR 26.792 million or INR 2.61 per basic and diluted share against INR 22.829 million or INR 2.23 per basic and diluted share a year ago.
Sunil Healthcare Ltd. to Report Q3, 2015 Results on Feb 11, 2015
Feb 6 15
Sunil Healthcare Ltd. announced that they will report Q3, 2015 results on Feb 11, 2015
Similar Private Companies By Industry
Recent Private Companies Transactions
July 14, 2014
Most Searched Private Companies
Sponsored Financial Commentaries